Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health Ltd is pleased to announce the appointment of JoyingBio (Hangzhou Jiuyang Biotechnology Co., Ltd.) as distributor in China for PCRD nucleic acid lateral flow immunoassays (NALFIA).

PCRD is a lateral flow immunoassay incorporating antibodies which capture and allow visualisation of double-stranded amplification products containing selected binding partners, FITC (or FAM) and Biotin, as well as DIG and Biotin. This simple method of amplicon detection takes only 10 minutes, and the result is detectable by eye due to an aggregation of carbon particles at the capture lines. PCRD is a rapid, safe and sensitive alternative to ethidium bromide staining of agarose gels.

JoyingBio specializes in R&D, manufacturing and distribution of instruments, reagents and consumables in the fields of life sciences, in vitro diagnostics, food safety and environment monitoring. With their many years experience of working in these industries JoyingBio are well placed to demonstrate to the Chinese market the many benefits of using PCRD.

More information about PCRD can be found by clicking on this link to our nucleic acid lateral flow assay information flyer.

Abingdon Health is continuing to seek commercial partners, who are active in the molecular biology field. If you would like to enquire about becoming a commercial partner for PCRD please contact us.

Source:

2016 AACC Annual Meeting Press Program

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024